Minerva Biotechnologies's cover image
Claim this profile

This profile has not been claimed by the business owner or representative.

Claim this business to update business information, get appointment requests, engage visitors with web chat, and more!

Minerva Biotechnologies

4.3

About this business

Minerva Biotechnologies is located at 40 Bear Hill Rd, Waltham, MA. This location is in the West End neighborhood.. 

Location details

40 Bear Hill Rd, Waltham, MA, 02451, United States

Get directions
WeekdayScheduleStatus
Mon9:00 a.m. to 6:00 p.m.
Tue9:00 a.m. to 6:00 p.m.
Wed9:00 a.m. to 6:00 p.m.
Thu9:00 a.m. to 6:00 p.m.
Fri9:00 a.m. to 6:00 p.m.
SatClosed
SunClosed
4.312 reviews
Select a rating
David Sutherland's profile image
David Sutherland 
on Google
10 months ago

As an investor for many years, we appreciate the open communication with Dr. Cynthia Bamdad and Ron Axelrod. They have always answered my questions and kept me well informed on their amazing progress to find a cure for Cancer. I am convinced of their dedication to achieve this noble goal and I am also impressed by their willingness to look out for the shareholders. I share in their expectations that such a success will also include substantial financial rewards for the investors. Good luck team Minerva! 

Rocco Restrepo's profile image
Rocco Restrepo 
on Google
11 months ago

I have been a shareholder at Minerva Biotechnologies since the beginning and I have subscribed to two rounds of fund raising. The team at Minerva have made many personal sacrifices in order to bring their science in combating cancer to where it is today. They are at the cusp of curing cancer and the resumption of the clinical trials later this year with the improved CAR T will bring them across the finish line. Cynthia and her team have been very good at keeping me as an investor informed of both the progress and the stumbli... read more

John Rogers's profile image
John Rogers 
on Google
11 months ago

Minerva is the rarest of biotech companies. It has taken the time to carefullly get the science right, had the courage to follow the science rather than be distracted by investor fads, and has maintained a single minded focus. It is now on the brink of being able to boast a major new class of, clinically proven, cancer therapeutics. Dr Bamdad's work will be appreciated by cancer patients and their families for decades to come. Proud to be a shareholder and long-term supporter! 

Eli Tobias's profile image
Eli Tobias 
on Google
11 months ago

The drugs employed in current day chemotherapy are largely potentially highly toxic and are also associated with the horrific clinical side effects patients are forced to endure . It is also widely acknowledged that the end results of this therapeutic approach leaves much to be desired , in fact decidedly poor ! In stark contrast to the above , it seems just possible. in fact highly likely , that what can only be described as a truly momentous development is about to occur . Several years ago Dr. Cynthia Bamdad made a brilli... read more

David Pohl's profile image
David Pohl 
on Google
11 months ago

I've been an investor in Minerva since 2017. As I was considering an investment, Minerva's top management took the time to meet with me individually to provide an in-depth presentation on the science behind the company. Since then, their technology has advanced even further and they have been open with sharing the positive progress, along with the challenges they've encountered. Their leadership team has always responded to my inquiries in a timely manner. If a call goes to voicemail, I've always received a call-back within ... read more

View all google reviews

Frequently asked questions about Minerva Biotechnologies

How is Minerva Biotechnologies rated?

Minerva Biotechnologies has a 4.3 star rating with 12 reviews. 

When is Minerva Biotechnologies open?

Minerva Biotechnologies is closed now. It will open tomorrow at 9:00 a.m. 

Need help? Contact us.

Speak with a specialist to learn how you can grow with Birdeye. We are reachable at profiles@birdeye.com